STAT - Reporting from the frontiers of health and medicine

Skip to Main Content

Read all of our coverage of the coronavirus and Covid-19.

Try STAT+ TODAY

June 30, 2023

Gilead and Teva defeat antitrust lawsuit that claimed prices for HIV medicines were unfairly kept high
June 30, 2023

The Supreme Court’s affirmative action decision puts lives at risk
June 30, 2023

Up and down the ladder: The latest comings and goings
June 30, 2023

Bright Health sells Medicare Advantage plans to Molina for $600 million
June 30, 2023

Medicare details the structure of its new drug price negotiation program
June 30, 2023

CMS must protect access to the ‘gold standard of breast reconstruction’

book

Decoding Medicare: 10 key decisions and how they're made

$399.00

Get The Report

Malaria cases in Florida and Texas: Here’s what you need to know

Scientists say five cases of locally-transmitted malaria in Florida and Texas are concerning but not cause for alarm.

In the Lab

STAT Plus: Global controversy heats up the race to build human embryo models from stem cells

Health

We have a cure for hepatitis C — so why aren’t more people getting treatment?

Sponsored

Advertisement

All First Opinion

STAT+

In-depth analysis of biotech, pharma, and the life sciences. Start your free trial.

30 days free. Cancel anytime.

Start free trial

Two type 1 diabetes patients now freed from insulin shots with cell therapy, Vertex reports

Medicare’s new proposal to cover medical devices draws a mixed reaction

Gilead and Teva defeat antitrust lawsuit that claimed prices for HIV medicines were unfairly kept high

Medicare details the structure of its new drug price negotiation program

All STAT+ Stories

All Events

More From STAT

More From STAT

More From STAT

STAT offers a variety of in-person and virtual events throughout the year.

All Events

2023 STAT Future Summit

Virtual September 5, 2023

Here’s an antidote to the rising cost of innovation: meet the pioneers who are leading the way to a new era of medicine, all in one place.

18

Jul

The State of Biosimilars: What to Watch

Virtual

17

Aug

STAT Locals Happy Hour

New York City, NY

18

Oct

2023 STAT Summit

Boston, MA

All Events

All Stories

Health

Malaria cases in Florida and Texas: Here’s what you need to know

Politics

After affirmative action ruling, medical education leaders see silver lining in court endorsement of ‘holistic review’

Breaking News

STAT Plus: Medicare details the structure of its new drug price negotiation program

Biotech

For Duchenne moms who pushed for cures, new breakthrough therapy can’t rebuild what’s lost

Health

New research underscores benefits of gender-affirming hormones, rebutting anti-trans claims

Health

Walensky prepares to leave CDC — and Congress — after a bruising 29 months

Exclusive

STAT Plus: FDA staff leaned toward rejecting Sarepta gene therapy before top official intervened

A STAT Investigation

STAT Plus: ‘It’s beyond unethical’: Opaque conflicts of interest permeate prescription drug benefits

First Opinion

23andMe had devastating news about my health. I wish a person had delivered it

First Opinion

How the conversation about moral injury in health care is changing

Special Report

The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race

First Opinion

Do masks work? Randomized controlled trials are the worst way to answer the question

Politics

STAT Plus: The strategy behind the pharmaceutical industry’s flurry of lawsuits challenging drug pricing reform

Politics

STAT Plus: 3 hurdles to bringing medical devices to the U.S. market

Morning Rounds

A drug pricing executive order & racial disparities in breast cancer

Pharmalot

STAT Plus: Pharmalittle: California transparency law stalls some price hikes; Pfizer reorganizes operations, again

Pharmalot

STAT Plus: European Parliament restricts antibiotic use in food-producing livestock

Health

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Pharmalot

STAT Plus: Gilead and Teva defeat antitrust lawsuit that claimed prices for HIV medicines were unfairly kept high

First Opinion

The Supreme Court’s affirmative action decision puts lives at risk

Pharmalot

STAT Plus: Up and down the ladder: The latest comings and goings

Insurance

STAT Plus: Bright Health sells Medicare Advantage plans to Molina for $600 million

Breaking News

STAT Plus: Medicare details the structure of its new drug price negotiation program

First Opinion

CMS must protect access to the ‘gold standard of breast reconstruction’

Health Tech

STAT Plus: Medicare’s new proposal to cover medical devices draws a mixed reaction

Biotech

STAT Plus: BioMarin wins approval for gene therapy to treat hemophilia A

Health

Stop taking Ozempic before surgery, anesthesiologist group recommends

The Readout LOUD

Novavax’s CEO promises a turnaround & how Lilly roiled the obesity market

Politics

Medical leaders decry Supreme Court decision on affirmative action

Biotech

STAT Plus: Alkermes shareholders re-elect directors, rebuffing effort by hedge fund Sarissa

Pharmalot

STAT Plus: SEC charges former Pfizer statistician with insider trading over Paxlovid clinical trial results

Politics

Supreme Court strikes down use of affirmative action, a blow to efforts to diversify medical schools

Pharmalot

STAT Plus: Pharmalittle: Drug-wholesaler owner indicted for alleged role in diverting HIV medicines; Catalent linked to Regeneron drug rejection

Pharmalot

STAT Plus: Drug wholesaler owner indicted for alleged role in diverting Gilead and J&J HIV medicines

First Opinion

The love my daughter and I found in the PICU

Pharma

STAT Plus: Evangelist for legalizing MDMA therapy wrestles with his ideals as psychedelics go pharma

Pharmalot

STAT Plus: Gilead and Teva defeat antitrust lawsuit that claimed prices for HIV medicines were unfairly kept high

Pharmalot

STAT Plus: Up and down the ladder: The latest comings and goings

Insurance

STAT Plus: Bright Health sells Medicare Advantage plans to Molina for $600 million

Pharmalot

STAT Plus: Pharmalittle: FDA approves BioMarin gene therapy for hemophilia A; former Pfizer worker charged with insider trading

Breaking News

STAT Plus: Medicare details the structure of its new drug price negotiation program

Health Tech

STAT Plus: Medicare’s new proposal to cover medical devices draws a mixed reaction

Biotech

STAT Plus: BioMarin wins approval for gene therapy to treat hemophilia A

Biotech

STAT Plus: Alkermes shareholders re-elect directors, rebuffing effort by hedge fund Sarissa

Pharmalot

STAT Plus: SEC charges former Pfizer statistician with insider trading over Paxlovid clinical trial results

Pharmalot

STAT Plus: Pharmalittle: Drug-wholesaler owner indicted for alleged role in diverting HIV medicines; Catalent linked to Regeneron drug rejection

Pharmalot

STAT Plus: Drug wholesaler owner indicted for alleged role in diverting Gilead and J&J HIV medicines

Pharma

STAT Plus: Evangelist for legalizing MDMA therapy wrestles with his ideals as psychedelics go pharma

Politics

STAT Plus: Trump demands the U.S. pay no more for drugs than other countries … again

Health Tech

STAT Plus: A replacement for race: Medical experts explore how to eliminate bias in clinical algorithms

Pharmalot

STAT Plus: Pharmalittle: FDA declines to approve higher dose version of Regeneron eye drug; FDA warns wholesaler over counterfeit HIV pills

Adam's Take

STAT Plus: Moonlake’s less-than-transparent data disclosures produced a cash windfall. Risks remain

Health

STAT Plus: The cancer drug shortage isn’t new — and neither are the solutions: ‘It’s like Groundhog Day’

Politics

STAT Plus: Protesters slam health insurance lobby for Medicare Advantage coverage restrictions

First Opinion

The Supreme Court’s affirmative action decision puts lives at risk

First Opinion

CMS must protect access to the ‘gold standard of breast reconstruction’

First Opinion

The love my daughter and I found in the PICU

First Opinion

Smoke from Canadian wildfires shows outdoor workers need air quality protections

Adam's Take

STAT Plus: Moonlake’s less-than-transparent data disclosures produced a cash windfall. Risks remain

First Opinion Podcast

Cancer drug shortages should be causing more outrage

First Opinion

It’s past time to address the problem of indoor air quality. A new technology can help

First Opinion

A seemingly small semantic issue is a major roadblock to develop treatments for rare diseases

First Opinion

CMS change could slow the crucial growth of ‘food as medicine’

First Opinion

Health misinformation is rampant in youth baseball. Why isn’t MLB doing more to help?

First Opinion

OB-GYNs could have solidified abortion as health care after Roe. They missed their chance

First Opinion

Peter Hotez is not alone: Online harassment of doctors is a public health issue

First Opinion

The staggering financial burden of giving birth — even with insurance

First Opinion

The FDA’s approval of a new gene therapy for Duchenne muscular dystrophy won’t help me — but it gives me hope

First Opinion

Former Surgeon General Jerome Adams: Prioritize new antivirals for Covid

First Opinion Podcast

How to save PrEP access — and even expand it

First Opinion

Pregnancy-related death, like Tori Bowie’s, is a far too common occurrence among Black women

First Opinion

Bloated patient records are filled with false information, thanks to copy-paste

Newsletters

Mon - Fri

Your daily dose of news in health and science

Elizabeth Cooney

Our Picks

Our Picks

STAT’s selection of must-read stories and investigations

The inside story of how data integrity issues roiled a biotech seen as ‘Moderna 2.0’

By Allison DeAngelis — STAT and Ryan Cross — The Boston Globe

In Belgium, a native son returns to resurrect the drugmaker Galapagos — and ‘to get the trust back’

By Damian Garde

Here’s why obesity grew so quickly worldwide, and where that’s starting to change

By Julia Belluz and J. Emory Parker

‘Stunning’ change to United’s colonoscopy coverage roils physicians and patients

What does generative AI mean for health care? We asked the experts

By Casey Ross, Brittany Trang and Mario Aguilar

ChatGPT in medicine: STAT answers readers’ burning questions about AI

By Lizzy Lawrence, Mohana Ravindranath and Brittany Trang

After decades of neglecting women athletes, sport and exercise medicine is finally catching up

By Amanda Loudin

Wealth, not health: For this hospital, closing Chicago’s alarming ‘death gap’ didn’t mean more clinics

By Usha Lee McFarling

For Duchenne moms who pushed for cures, new breakthrough therapy can’t rebuild what’s lost

Biotech

For Duchenne moms who pushed for cures, new breakthrough therapy can’t rebuild what’s lost

Biotech

STAT Plus: BioMarin wins approval for gene therapy to treat hemophilia A

Biotech

STAT Plus: Alkermes shareholders re-elect directors, rebuffing effort by hedge fund Sarissa

STAT Plus: Gilead and Teva defeat antitrust lawsuit that claimed prices for HIV medicines were unfairly kept high

Pharmalot

STAT Plus: Gilead and Teva defeat antitrust lawsuit that claimed prices for HIV medicines were unfairly kept high

Pharmalot

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot

STAT Plus: Pharmalittle: FDA approves BioMarin gene therapy for hemophilia A; former Pfizer worker charged with insider trading

Malaria cases in Florida and Texas: Here’s what you need to know

Health

Malaria cases in Florida and Texas: Here’s what you need to know

Biotech

For Duchenne moms who pushed for cures, new breakthrough therapy can’t rebuild what’s lost

Health

Stop taking Ozempic before surgery, anesthesiologist group recommends

After affirmative action ruling, medical education leaders see silver lining in court endorsement of ‘holistic review’

Politics

After affirmative action ruling, medical education leaders see silver lining in court endorsement of ‘holistic review’

Breaking News

STAT Plus: Medicare details the structure of its new drug price negotiation program

Politics

Medical leaders decry Supreme Court decision on affirmative action

Video

Why do we get seasonal allergies?

STAT Plus: P-value, an important measurement in clinical trials, explained

The strange history of BMI, the body mass index

STAT Plus: Blockbuster drug Humira has new competition. Here’s why that matters

Biotechnology

Biotechnology

STAT Plus: Medicare’s new proposal to cover medical devices draws a mixed reaction

Health Tech

STAT Plus: Medicare’s new proposal to cover medical devices draws a mixed reaction

Health Tech

STAT Plus: A replacement for race: Medical experts explore how to eliminate bias in clinical algorithms

Health Tech

STAT Plus: For volunteers at an eating disorder hotline, being replaced by an AI chatbot carried a painful cost

STAT Plus: Global controversy heats up the race to build human embryo models from stem cells

In the Lab

STAT Plus: Global controversy heats up the race to build human embryo models from stem cells

Politics

STAT Plus: House GOP inquiry over gain-of-function research targets a scientific giant

In the Lab

Scientists successfully unfroze rat organs and transplanted them — a ‘historic’ step that could someday transform transplant medicine

STAT Plus: UnitedHealth wins $3.3 billion takeover of home health giant Amedisys

Insurance

STAT Plus: UnitedHealth wins $3.3 billion takeover of home health giant Amedisys

Insurance

STAT Plus: UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

Hospitals

Cross-border ‘twinning programs’ may reduce survival disparities for childhood leukemia

STAT Plus: Bright Health sells Medicare Advantage plans to Molina for $600 million

Insurance

STAT Plus: Bright Health sells Medicare Advantage plans to Molina for $600 million

Politics

STAT Plus: Protesters slam health insurance lobby for Medicare Advantage coverage restrictions

Insurance

STAT Plus: UnitedHealth wins $3.3 billion takeover of home health giant Amedisys

Podcasts

Novavax’s CEO promises a turnaround & how Lilly roiled the obesity market

Cancer drug shortages should be causing more outrage

Messy PBM conflicts, debatable vaccines, & the future of flu season

How to save PrEP access — and even expand it